Medicure Inc.

C$3.75As of Sun 8 Nov 2026, 12:00 UTC
TSXV:MPHHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (4.39%)
Div yield —
ROE (49.88%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.21
PE TTM —
TSR TTM 223.28%
Mkt cap C$39.14M
ROIC (64.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.53
20.89%
(74.64%)
Sell 0|6|1|8|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.07
0.08
11.92%
6.71%
13.19%
29.75%
Revenue$M
3.715
3.758
3.688
3.683
11.62%
10.52%
2.50%
(2.94%)
Peers (US$27.70M)
Cap (US$)
PE
24.68M
—
Capital
TTM
5Y
10Y
Leveragex
0.638
0.166
0.129
EBIT/Intx
0.409
1.341
1.427
Own earn%
(0.85)
(10.08)
(13.06)
Sh yield%
36.92
19.20
22.56
Owners
Insiders/Inst%
8.93
51.91
Short interest%
3.65
SBC / revenue%
4.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
10–14
$1 testx
—
Incr. ROIC%
3